DK246786A - Laegemiddel indeholdende vaevs-plasminogen-aktivator - Google Patents

Laegemiddel indeholdende vaevs-plasminogen-aktivator Download PDF

Info

Publication number
DK246786A
DK246786A DK246786A DK246786A DK246786A DK 246786 A DK246786 A DK 246786A DK 246786 A DK246786 A DK 246786A DK 246786 A DK246786 A DK 246786A DK 246786 A DK246786 A DK 246786A
Authority
DK
Denmark
Prior art keywords
plasminogen activator
containing pharmaceutical
pharmaceuticals containing
pharmaceuticals
pharmaceutical
Prior art date
Application number
DK246786A
Other languages
English (en)
Other versions
DK163173C (da
DK163173B (da
DK246786D0 (da
Inventor
Michael Denis Johnston
Henry Berger
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858513358A external-priority patent/GB8513358D0/en
Priority claimed from GB858521705A external-priority patent/GB8521705D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK246786D0 publication Critical patent/DK246786D0/da
Publication of DK246786A publication Critical patent/DK246786A/da
Publication of DK163173B publication Critical patent/DK163173B/da
Application granted granted Critical
Publication of DK163173C publication Critical patent/DK163173C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK246786A 1985-05-28 1986-05-27 Fremgangsmaade til fremstilling af et lyofiliseret farmaceutisk praeparat af vaevs-plasminogenaktivator (t-pa) DK163173C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB858513358A GB8513358D0 (en) 1985-05-28 1985-05-28 Formulation
GB8513358 1985-05-28
GB858521705A GB8521705D0 (en) 1985-08-31 1985-08-31 Formulation
GB8521705 1985-08-31

Publications (4)

Publication Number Publication Date
DK246786D0 DK246786D0 (da) 1986-05-27
DK246786A true DK246786A (da) 1986-11-29
DK163173B DK163173B (da) 1992-02-03
DK163173C DK163173C (da) 1992-06-22

Family

ID=26289290

Family Applications (1)

Application Number Title Priority Date Filing Date
DK246786A DK163173C (da) 1985-05-28 1986-05-27 Fremgangsmaade til fremstilling af et lyofiliseret farmaceutisk praeparat af vaevs-plasminogenaktivator (t-pa)

Country Status (22)

Country Link
US (2) US4929444A (da)
JP (1) JPH0759517B2 (da)
AU (1) AU567236B2 (da)
BE (1) BE904830A (da)
CA (1) CA1300008C (da)
CH (1) CH665356A5 (da)
DE (1) DE3617752A1 (da)
DK (1) DK163173C (da)
ES (2) ES8800601A1 (da)
FI (1) FI85335C (da)
FR (1) FR2583984B1 (da)
GB (1) GB2176702B (da)
GR (1) GR861366B (da)
HU (1) HU195733B (da)
IL (1) IL78938A (da)
IT (1) IT1191926B (da)
LU (1) LU86444A1 (da)
NL (1) NL8601355A (da)
NO (1) NO171345C (da)
NZ (1) NZ216307A (da)
PT (1) PT82646B (da)
SE (1) SE462016B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO171344C (no) * 1985-05-28 1993-03-03 Wellcome Found Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
US5034225A (en) * 1985-12-17 1991-07-23 Genentech Inc. Stabilized human tissue plasminogen activator compositions
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
US4976959A (en) * 1986-05-12 1990-12-11 Burroughs Wellcome Co. T-PA and SOD in limiting tissue damage
JPH0680015B2 (ja) * 1986-05-12 1994-10-12 ザ ウエルカム ファウンデーション リミテッド 医薬組成物
GB8619098D0 (en) * 1986-08-05 1986-09-17 Wellcome Found Combination
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5342616A (en) * 1988-06-20 1994-08-30 The Wellcome Foundation Limited Method of administering tissue plasminogen activator
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
DE3835350A1 (de) * 1988-10-17 1990-04-19 Boehringer Mannheim Gmbh Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
DE3942142A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von glykosyliertem t-pa
WO1992011866A1 (en) * 1991-01-14 1992-07-23 Duke University LAMININ SEQUENCE AS tPA ACTIVATOR
DE69333127T2 (de) * 1992-06-03 2004-05-06 Genentech, Inc., South San Francisco Varianten des Gewebeplasminogenaktivators mit verbesserter therapeutischer Wirkung
JP3840262B2 (ja) * 1995-10-23 2006-11-01 ザ チルドレンズ メディカル センター コーポレイション 治療用の抗血管新生組成物および方法
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
KR100477280B1 (ko) * 1995-12-13 2005-07-18 아보트 러보러터리즈 맥관형성에의한질환치료제
DE69719265T2 (de) * 1996-09-06 2003-12-04 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute, Kumamoto Medizinische Zusammensetzung die Gewebeplasminogenaktivator und Nikotinamid enthält
US20030077682A1 (en) * 2001-09-07 2003-04-24 Hung Paul Porwen Human tissue urokinase type plasminogen activator formulation
US20040091465A1 (en) * 2002-06-26 2004-05-13 Zachary Yim Therapeutic antiangiogenic compositions and methods
EP1636337A4 (en) * 2003-06-20 2007-07-04 Illumina Inc METHODS AND COMPOSITIONS USEFUL FOR THE AMPLIFICATION AND GENOTYPING OF THE GENOME
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
US8822535B2 (en) * 2005-04-20 2014-09-02 Fred Hutchinson Cancer Research Center Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
FR2252842B1 (da) * 1973-12-03 1977-11-04 Fabre Sa Pierre
DE3015699C2 (de) * 1979-04-26 1982-07-15 Asahi Kasei Kogyo K.K., Osaka Herstellung eines Plasminogen-Aktivators
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
JPS5951220A (ja) * 1982-08-02 1984-03-24 Asahi Chem Ind Co Ltd 新規なプラスミノ−ゲン・アクチベ−タ−およびその製法ならびにこれを含有する薬剤
EP0124613B1 (en) * 1982-10-29 1992-12-30 MITSUI TOATSU CHEMICALS, Inc. Novel plasminogen activator derived from human kidneys, process for its preparation, and thrombolytic drug containing the same
AU554862B2 (en) * 1982-12-14 1986-09-04 Implico B.V. Plasminogen activator isolated by affinity chromatography
NZ206699A (en) * 1982-12-30 1989-08-29 Bio Response Inc Process for the production of serum independent cell lines
JPS59196824A (ja) * 1983-04-21 1984-11-08 Kowa Co 吸着防止剤
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
DE3439980A1 (de) * 1984-11-02 1986-05-07 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung sowie pasteurisierung von urokinase
EP0201153A3 (en) * 1985-02-09 1987-10-07 Beecham Group Plc Modified enzyme and process for its preparation
GB8513358D0 (en) * 1985-05-28 1985-07-03 Wellcome Found Formulation
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法

Also Published As

Publication number Publication date
AU567236B2 (en) 1987-11-12
FR2583984B1 (fr) 1989-06-02
PT82646B (pt) 1989-01-30
GB2176702B (en) 1989-07-05
SE8602405D0 (sv) 1986-05-27
GB2176702A (en) 1987-01-07
FR2583984A1 (fr) 1987-01-02
AU5796486A (en) 1986-12-04
IT1191926B (it) 1988-03-31
SE462016B (sv) 1990-04-30
LU86444A1 (fr) 1986-12-05
IL78938A0 (en) 1986-09-30
IL78938A (en) 1993-02-21
DE3617752A1 (de) 1986-12-04
DK163173C (da) 1992-06-22
FI862227L (fi) 1986-11-29
IT8648065A0 (it) 1986-05-27
ES8800601A1 (es) 1987-11-16
NO171345C (no) 1993-03-03
NO171345B (no) 1992-11-23
US4929444A (en) 1990-05-29
HU195733B (en) 1988-07-28
CA1300008C (en) 1992-05-05
US4968617A (en) 1990-11-06
GR861366B (en) 1986-09-29
NO862096L (no) 1986-12-01
BE904830A (fr) 1986-11-27
PT82646A (en) 1986-06-01
FI862227A0 (fi) 1986-05-27
GB8612780D0 (en) 1986-07-02
ES555353A0 (es) 1987-11-16
NL8601355A (nl) 1986-12-16
CH665356A5 (de) 1988-05-13
DK163173B (da) 1992-02-03
ES557374A0 (es) 1988-06-01
JPH06183995A (ja) 1994-07-05
DK246786D0 (da) 1986-05-27
NZ216307A (en) 1989-10-27
FI85335C (fi) 1992-04-10
HUT41638A (en) 1987-05-28
JPH0759517B2 (ja) 1995-06-28
DE3617752C2 (da) 1988-06-30
SE8602405L (sv) 1986-11-29
FI85335B (fi) 1991-12-31
ES8802439A1 (es) 1988-06-01

Similar Documents

Publication Publication Date Title
DK246786D0 (da) Laegemiddel indeholdende vaevs-plasminogen-aktivator
DK462486D0 (da) Farmaceutisk tablet indeholdende cefuroxim-axetil
DK34186A (da) Skruekapsel til flaske
MX9203170A (es) Composicion farmaceutica con actividad analgesica.
DK1790A (da) Laegemidler indeholdende insulinderivater
ATA290487A (de) Pharmazeutika enthaltend pyrozole
DE3676760D1 (de) Poly-kringle-plasminogenaktivator.
DK162986C (da) 4-substituerede 2-amino-5-hydroxypyrimidin-forbindelser og farmaceutiske praeparater indeholdende disse
FI863077A7 (fi) Farmaseuttinen annosyksikkö.
FR2590799B1 (fr) Seringue
DK259186A (da) Nasale farmaceutiske praeparater
DK548689A (da) Farmaceutisk oploesning
DK52086D0 (da) Farmaceutiske praeparater indeholdende ergotalkaloider
DK259586D0 (da) Farmaceutisk tablet
IT1200467B (it) Formulazione farmaceutica
DK162086A (da) Laegemiddel indeholdende vaevs-plasminogenaktivator, dets fremstilling og anvendelse
DK52186A (da) Farmaceutisk praeparat indeholdende indolderivater
DK60187A (da) Bis-diozopiperazin-derivater og laegemiddelformuleringer indeholdende saadanne forbindelser
RO91711A2 (ro) Produs medicamentos reconfortant
SE8503858D0 (sv) Novel pharmaceutical applications
SE8504793D0 (sv) Pharmaceutical preparations
NO873145D0 (no) Transdermal avlevering av legemidler.
ES284799Y (es) Frasco dosificador
ATE59857T1 (de) Poly-kringle-plasminogenaktivator.
NO873245D0 (no) Nye fosforbindelser og legemiddel inneholdende disse.

Legal Events

Date Code Title Description
PBP Patent lapsed